2-Year Outcomes Following Transseptal Mitral Valve Replacement With the HighLife System
Open Access
- 11 May 2026
- journal article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 19 (9) , 1155-1157
Abstract
No abstract availableKeywords
Funding Information
- Warszawski Uniwersytet Medyczny
- Śląski Uniwersytet Medyczny w Katowicach
This publication has 4 references indexed in Scilit:
- Percutaneous transcatheter valve replacement in individuals with mitral regurgitation unsuitable for surgery or transcatheter edge-to-edge repair: a prospective, multicountry, single-arm trialThe Lancet, 2025
- 1-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve ReplacementJACC: Cardiovascular Interventions, 2023
- Clinical outcomes of transcatheter mitral valve replacement: two-year results of the CHOICE-MI RegistryEuroIntervention, 2023
- 2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral RegurgitationJACC, 2021